JNJ vs EW
By Alex · Tickerpine
Johnson & Johnson vs Edwards Lifesciences Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | EW |
|---|---|---|
| Price | $285.75 | $107.15 |
| Market cap | $687.89B | $61.61B |
| P/E ratio | 43.4 | 62.3 |
| ROE | 20.02% | 9.33% |
| Profit margin | 16.20% | 15.30% |
| Revenue growth | 5.90% | 10.50% |
| Dividend yield | 1.88% | 0.00% |
| Beta | 0.20 | 0.83 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs EW in plain English
- JNJ is the bigger company — about 11.2× the market cap of EW.
- JNJ is cheaper on earnings (P/E 43.4 vs 62.3).
- JNJ earns a higher return on equity (20% vs 9%).
- EW is growing revenue faster (10% vs 6%).
- JNJ pays a dividend (1.88%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
EW return calculator
See what $1,000 in Edwards Lifesciences Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.